Initially, we confirmed this result by transiently expressing parkin in human embryonic kidney (HEK)-293 or human neuroblastoma SH-SY5Y cells and monitoring p53 promoter activity using a luciferase reporter assay. The gene discussed is PRKN; the disease is neuroblastoma.